Experience

IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, acquired Precision Healthcare.

Waller acted as corporate counsel to IVX Health in connection with the acquisition, as well as two concurrent preferred equity financings - one from Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare sector, and the other from certain existing investors in IVX Health, including CrimsoNox Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.